Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-resistant Escherichia Coli Clonal Group
Overview
Affiliations
Background: The management of urinary tract infections is complicated by the increasing prevalence of antibiotic-resistant strains of Escherichia coli. We studied the clonal composition of E. coli isolates that were resistant to trimethoprim-sulfamethoxazole from women with community-acquired urinary tract infections.
Methods: Prospectively collected E. coli isolates from women with urinary tract infections in a university community in California were evaluated for antibiotic susceptibility, O:H serotype, DNA fingerprinting, pulsed-field gel electrophoretic pattern, and virulence factors. The prevalence and characteristics of an antibiotic-resistant clone were evaluated in this group of isolates and in those from comparison cohorts in Michigan and Minnesota.
Results: Fifty-five of the 255 E. coli isolates (22 percent) from the California cohort were resistant to trimethoprim-sulfamethoxazole as well as other antibiotics. There was a common pattern of DNA fingerprinting, suggesting that the isolates belonged to the same clonal group (clonal group A), in 28 of 55 isolates with trimethoprim-sulfamethoxazole resistance (51 percent) and in 2 of 50 randomly selected isolates that were susceptible to trimethoprim-sulfamethoxazole (4 percent, P<0.001). In addition, 11 of 29 resistant isolates (38 percent) from the Michigan cohort and 7 of 18 (39 percent) from the Minnesota cohort belonged to clonal group A. Most of the clonal group A isolates were serotype O11:H(nt) or O77:H(nt), with similar patterns of virulence factors, antibiotic susceptibility, and electrophoretic features.
Conclusions: In three geographically diverse communities, a single clonal group accounted for nearly half of community-acquired urinary tract infections in women that were caused by E. coli strains with resistance to trimethoprim-sulfamethoxazole. The widespread distribution and high prevalence of E. coli clonal group A has major public health implications.
Nkhebenyane S, Khasapane N, Lekota K, Thekisoe O, Ramatla T Foods. 2024; 13(23).
PMID: 39683033 PMC: 11641425. DOI: 10.3390/foods13233961.
Young M, Straub T, Worby C, Metsky H, Gnirke A, Bronson R Nat Commun. 2024; 15(1):9466.
PMID: 39487120 PMC: 11530686. DOI: 10.1038/s41467-024-53829-7.
Armah E, Osae-Nyarko L, Idun B, Ahiabu M, Agyapong I, Kwarteng F Genes (Basel). 2024; 15(8).
PMID: 39202346 PMC: 11354122. DOI: 10.3390/genes15080985.
Karas D, Upadhyayula S, Love A, Bigham M Pediatr Qual Saf. 2024; 8(3):e655.
PMID: 38571730 PMC: 10990320. DOI: 10.1097/pq9.0000000000000655.
Polyphenolic compounds in the combat of foodborne infections - An update on recent evidence.
Menikheim C, Mousavi S, Bereswill S, Heimesaat M Eur J Microbiol Immunol (Bp). 2024; 14(2):116-125.
PMID: 38526560 PMC: 11097791. DOI: 10.1556/1886.2024.00018.